Purchase Order N0025908P0248
Award Date 11/8/07
Potential Completion Date 11/13/07
Potential Value $8.5K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20878, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Hologic, Inc. for HPV testing on December 13, 2024, with a ceiling value of $87,400.00. Work is performed in Marlborough, Massachusetts. The order covers HPV testing cost per reportable case, with a firm fixed price structure and an ultimate completion date of December 11, 2029. The procurement originated from a Request for Quotation posted October 22, 2024, for Washington DC VA Medical...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention....
- Veterans Integrated Service Network 8 awarded a purchase order to Hologic Sales and Service, LLC for HPV testing on October 1, 2023, with a ceiling value of $2,300,610.84 and ultimate completion date of September 30, 2028. Place of performance is Marlborough, Massachusetts. The order supplies HPV testing kits and related molecular diagnostic reagents to support laboratory testing operations across VA facilities, with an estimated annual volume exceeding 2,100 HPV tests. The contract carries firm...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract worth $150,000.00 to Georgia Tech Research Corporation to develop a broad spectrum human papillomavirus (HPV) genotyping test. The contract is a sole source award made under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). The contract is for the development of an advanced molecular detection (AMD) technology and bioinformatics-based HPV genotyping...
- This is a federal contract award to Hologic, Inc., a medical technology company, by the Defense Health Agency (DHA). The contract is for the provision of HPV testing products and services, with a potential value of $321,968.08 and a completion date of March 30, 2022. The contract type is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing mechanism. The place of performance is Fort Belvoir, VA. This award is not associated with a set-aside program. Hologic, Inc. is the prime...
- This firm-fixed-price purchase order, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., doing business as Creative Biomart, provides $55,100.00 for HPV genotyping and 16S rRNA sequencing services. The contract supports research on the progression of HPV-related diseases and dysplasia in individuals with primary and acquired immunodeficiencies. CD Biosciences, an incumbent supplier, will conduct HPV genotyping for 210 types and 16S rRNA...
- Roche Diagnostics Corporation was awarded a $56,875.60 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to provide HPV test kits. The contract was awarded on October 1, 2021 and has a completion date of September 30, 2022. It was issued against the Critical Analyzers, Laboratory GSA Schedule with contract number FSS-66-III and does not contain any set aside designations....
- This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...
- This federal contract award, with an ID of 75N91021P00756, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $95,995 firm-fixed-price purchase order was awarded to Atila Biosystems Incorporated, a small business, to provide HPV genotyping assays and testing supplies to support the NCI's Division of Cancer Epidemiology and Genetics (DCEG) research efforts. The contract was...
- This is a firm-fixed price purchase order awarded to Roche Diagnostics Corporation by the U.S. Army Medical Command (MEDCOM) for the provision of 960 HPV (Human Papillomavirus) detection kits. The contract has a ceiling value of $388,211.32 and a performance period ending on September 30, 2022. The contract was awarded on October 1, 2019 and does not have a set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
HPV HIGH RISK DNA TEST
Posted 11/8/07
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 2/7/08 | |
| Not listed | Not listed | $8.5k | 11/8/07 |